SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Logue Daniel V.

(Last) (First) (Middle)
550 E. SWEDESFORD ROAD
SUITE 400

(Street)
WAYNE PA 19087

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
01/29/2021
3. Issuer Name and Ticker or Trading Symbol
TELEFLEX INC [ TFX ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
VP, Gen Counsel & Secretary
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 8,780.888(1) D
Common Stock 294.595 I By 401(k) Trustee
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option / (Right to Buy) (2) 02/26/2024 Common Stock 1,525 101.12 D
Stock Option / (Right to Buy) (3) 02/25/2025 Common Stock 1,620 121 D
Stock Option / (Right to Buy) (4) 03/01/2026 Common Stock 1,574 144.79 D
Stock Option / (Right to Buy) (5) 02/28/2027 Common Stock 1,276 191.18 D
Stock Option / (Right to Buy) (6) 02/27/2028 Common Stock 843 253.72 D
Stock Option / (Right to Buy) (7) 02/26/2029 Common Stock 1,551 288.38 D
Stock Option / (Right to Buy) (8) 02/25/2030 Common Stock 1,180 348.11 D
Explanation of Responses:
1. Represents the total of 8139.888 shares held directly by the reporting person, 346 shares underlying a restricted stock award granted on 2/27/18, 174 shares underlying a restricted stock award granted on 2/26/19, and 121 shares underlying a restricted stock award granted on 2/25/20. The restricted stock awards vest 100% on the third anniversary of the grant date.
2. Exercisable for one-third of the shares on each of 2/26/2015, 2/26/2016 and 2/26/2017.
3. Exercisable for one-third of the shares on each of 2/25/2016, 2/25/2017 and 2/25/2018.
4. Exercisable for one-third of the shares on each of 3/1/2017, 3/1/2018 and 3/1/2019.
5. Exercisable for one-third of the shares on each of 2/28/2018, 2/28/2019 and 2/28/2020.
6. Exercisable for one-third of the shares on each of 2/27/2019, 2/27/2020 and 2/27/2021.
7. Exercisable for one-third of the shares on each of 2/26/2020, 2/26/2021 and 2/26/2022.
8. Exercisable for one-third of the shares on each of 2/25/2021, 2/25/2022 and 2/25/2023.
Remarks:
Daniel V. Logue 02/02/2021
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.